标题
Molecular profiling for precision cancer therapies
作者
关键词
-
出版物
Genome Medicine
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-01-15
DOI
10.1186/s13073-019-0703-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Tumor mutational burden (TMB) standardization initiatives: Recommendations for consistent TMB assessment in clinical samples to guide immunotherapy treatment decisions
- (2019) Albrecht Stenzinger et al. GENES CHROMOSOMES & CANCER
- Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions
- (2019) Vitor H. Teixeira et al. NATURE MEDICINE
- Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers
- (2019) Ruth Nussinov et al. PLoS Computational Biology
- New clinical trial designs in the era of precision medicine
- (2019) Elena Garralda et al. Molecular Oncology
- Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas
- (2019) Anne-Katrin Hickmann et al. BMC CANCER
- Molecular screening to select therapy for advanced cancer?
- (2019) I F Tannock et al. ANNALS OF ONCOLOGY
- Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial
- (2019) O Trédan et al. ANNALS OF ONCOLOGY
- Germline-Focused Analysis of Tumour-Only Sequencing: Recommendations from the ESMO Precision Medicine Working Group
- (2019) D Mandelker et al. ANNALS OF ONCOLOGY
- Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine
- (2019) Giovanna Rossi et al. CANCER RESEARCH
- A Canadian guideline on the use of next-generation sequencing in oncology
- (2019) S. Yip et al. Current Oncology
- Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from TRK Inhibitor Therapy
- (2019) Susan J. Hsiao et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
- (2019) Jason K. Sicklick et al. NATURE MEDICINE
- Long-Read Sequencing Emerging in Medical Genetics
- (2019) Tuomo Mantere et al. Frontiers in Genetics
- Tumour lineage shapes BRCA-mediated phenotypes
- (2019) Philip Jonsson et al. NATURE
- High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer
- (2019) Birgitte Bertelsen et al. npj Genomic Medicine
- Passenger Hotspot Mutations in Cancer
- (2019) Julian M. Hess et al. CANCER CELL
- A predictor of early disease recurrence in breast cancer patients using a cell-free RNA and protein liquid biopsy
- (2019) Annette Lasham et al. Clinical Breast Cancer
- Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update—Integration of Results From TAILORx
- (2019) Fabrice Andre et al. JOURNAL OF CLINICAL ONCOLOGY
- The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs
- (2019) D. L. van der Velden et al. NATURE
- Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia
- (2019) Andrea Rzepiel et al. Journal of Translational Medicine
- Targets, pitfalls and reference materials for liquid biopsy tests in cancer diagnostics
- (2019) Edward Geeurickx et al. MOLECULAR ASPECTS OF MEDICINE
- Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis
- (2019) Akihide Yoshimi et al. NATURE
- Pan-cancer whole-genome analyses of metastatic solid tumours
- (2019) Peter Priestley et al. NATURE
- Pathogenic Germline Variants in 10,389 Adult Cancers
- (2018) Kuan-lin Huang et al. CELL
- Precision Oncology Decision Support: Current Approaches and Strategies for the Future
- (2018) Katherine C. Kurnit et al. CLINICAL CANCER RESEARCH
- Complex rearrangements and oncogene amplifications revealed by long-read DNA and RNA sequencing of a breast cancer cell line
- (2018) Maria Nattestad et al. GENOME RESEARCH
- Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
- (2018) François-Clément Bidard et al. JNCI-Journal of the National Cancer Institute
- NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018
- (2018) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
- (2018) Andrew Tutt et al. NATURE MEDICINE
- Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
- (2018) Bjoern Chapuy et al. NATURE MEDICINE
- Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
- (2018) Jean-Charles Soria et al. NEW ENGLAND JOURNAL OF MEDICINE
- Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma
- (2018) S. Manier et al. Nature Communications
- Cancer epigenetics: Moving forward
- (2018) Angela Nebbioso et al. PLoS Genetics
- Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
- (2018) François-Clément Bidard et al. JNCI-Journal of the National Cancer Institute
- Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer
- (2018) Heather Hampel et al. JAMA Oncology
- Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non–Small Cell Lung Cancer in the Community Oncology Setting
- (2018) Carolyn J. Presley et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Her-2/neu Oncogene Amplification By Fluorescence In Situ Hybridization And Protein Overexpression On Immunohistochemistry In Breast Cancer
- (2018) Fouzia Lateef et al. JCPSP-Journal of the College of Physicians and Surgeons Pakistan
- Impact of a cognitive computing clinical trial matching system in an ambulatory oncology practice.
- (2018) Tufia C. Haddad et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular analysis for therapy choice (MATCH) arm W: Phase II study of AZD4547 in patients with tumors with aberrations in the FGFR pathway.
- (2018) Young Kwang Chae et al. JOURNAL OF CLINICAL ONCOLOGY
- Results from molecular analysis for therapy choice (MATCH) arm I: Taselisib for PIK3CA-mutated tumors.
- (2018) Ian E. Krop et al. JOURNAL OF CLINICAL ONCOLOGY
- Ado-trastuzumab emtansine (T-DM1) in patients (pts) with HER2 amplified (amp) tumors excluding breast and gastric/gastro-esophageal junction (GEJ) adenocarcinomas: Results from the National Cancer Institute (NCI) Molecular Analysis for Therapy Choice (MATCH) trial.
- (2018) Komal L. Jhaveri et al. JOURNAL OF CLINICAL ONCOLOGY
- Blood-based tumour mutational burden analysis in NSCLC
- (2018) Manjulika Das LANCET ONCOLOGY
- Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours
- (2018) Xiaotu Ma et al. NATURE
- The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space
- (2018) Johanna Klughammer et al. NATURE MEDICINE
- Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
- (2018) David R. Gandara et al. NATURE MEDICINE
- dbCPM: a manually curated database for exploring the cancer passenger mutations
- (2018) Zhenyu Yue et al. BRIEFINGS IN BIOINFORMATICS
- A biobank of patient-derived pediatric brain tumor models
- (2018) Sebastian Brabetz et al. NATURE MEDICINE
- Current and future perspectives of liquid biopsies in genomics-driven oncology
- (2018) Ellen Heitzer et al. NATURE REVIEWS GENETICS
- PreMedKB: an integrated precision medicine knowledgebase for interpreting relationships between diseases, genes, variants and drugs
- (2018) Ying Yu et al. NUCLEIC ACIDS RESEARCH
- Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
- (2018) Razvan Cristescu et al. SCIENCE
- Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine
- (2018) Jake R. Conway et al. Genome Medicine
- Is Precision Medicine an Oxymoron?
- (2018) S. Gail Eckhardt et al. JAMA Oncology
- Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
- (2017) Suzanne George et al. IMMUNITY
- Comparison of gefitinib, erlotinib and afatinib in non-small cell lung cancer: A meta-analysis
- (2017) Zuyao Yang et al. INTERNATIONAL JOURNAL OF CANCER
- Precision oncology based on omics data: The NCT Heidelberg experience
- (2017) Peter Horak et al. INTERNATIONAL JOURNAL OF CANCER
- Routine molecular screening of advanced refractory cancer patients: An analysis of the first 2490 patients of the ProfiLER study.
- (2017) Olivier Tredan et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide
- (2017) Emmanuel S. Antonarakis et al. JOURNAL OF CLINICAL ONCOLOGY
- High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods
- (2017) Dan Su et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
- (2017) Marilyn M. Li et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Dabrafenib plus trametinib in patients with previously untreated BRAF V600E -mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
- (2017) David Planchard et al. LANCET ONCOLOGY
- Next-generation sequencing reveals novel resistance mechanisms and molecular heterogeneity in EGFR-mutant non-small cell lung cancer with acquired resistance to EGFR-TKIs
- (2017) Choong-kun Lee et al. LUNG CANCER
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
- (2017) Christopher Abbosh et al. NATURE
- CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer
- (2017) Malachi Griffith et al. NATURE GENETICS
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
- (2017) Helen Davies et al. NATURE MEDICINE
- Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
- (2017) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non‐Small Cell Lung Cancer: First‐Line Therapy and Beyond
- (2017) Lee Pai‐Scherf et al. ONCOLOGIST
- Precision Oncology: The Road Ahead
- (2017) Daniela Senft et al. TRENDS IN MOLECULAR MEDICINE
- High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
- (2017) Christophe Massard et al. Cancer Discovery
- Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer
- (2017) Scott Gettinger et al. Cancer Discovery
- Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies
- (2017) Ryan J. Hartmaier et al. Genome Medicine
- Osimertinib: A third-generation tyrosine kinase inhibitor for treatment of epidermal growth factor receptor-mutated non-small cell lung cancer with the acquired Thr790Met mutation
- (2017) Meredith K Bollinger et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Appropriateness: A Key to Enabling the Use of Genomics in Clinical Practice?
- (2016) Jason L. Vassy et al. AMERICAN JOURNAL OF MEDICINE
- Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples
- (2016) L. A. Renfro et al. ANNALS OF ONCOLOGY
- Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: Cross-over analysis from the SHIVA trial
- (2016) L. Belin et al. ANNALS OF ONCOLOGY
- A survey of physician receptivity to molecular diagnostic testing and readiness to act on results for early-stage colon cancer patients
- (2016) Ronald E. Myers et al. BMC CANCER
- The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery
- (2016) Hendrik G. Stunnenberg et al. CELL
- dbNSFP v3.0: A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site SNVs
- (2016) Xiaoming Liu et al. HUMAN MUTATION
- Comparison of Next-Generation Sequencing Panels and Platforms for Detection and Verification of Somatic Tumor Variants for Clinical Diagnostics
- (2016) Maksym Misyura et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- NCCN Guidelines Insights: Melanoma, Version 3.2016
- (2016) Daniel G. Coit et al. Journal of the National Comprehensive Cancer Network
- Predictive biomarkers for checkpoint inhibitor-based immunotherapy
- (2016) Geoffrey T Gibney et al. LANCET ONCOLOGY
- Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer
- (2016) Gregor Tevz et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Genomically Driven Tumors and Actionability across Histologies: BRAF-Mutant Cancers as a Paradigm
- (2016) M. L. Turski et al. MOLECULAR CANCER THERAPEUTICS
- PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
- (2016) Paul T. Nghiem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
- (2016) F. Scherer et al. Science Translational Medicine
- Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
- (2016) Daniel Sanghoon Shin et al. Cancer Discovery
- Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial
- (2016) Tracy L. Stockley et al. Genome Medicine
- Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA
- (2016) Kasmintan A. Schrader et al. JAMA Oncology
- Prospective Validation of Rapid Plasma Genotyping for the Detection ofEGFRandKRASMutations in Advanced Lung Cancer
- (2016) Adrian G. Sacher et al. JAMA Oncology
- Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients
- (2016) Steffen Dietz et al. PLoS One
- Comparison of Next-Generation Sequencing and Mutation-Specific Platforms in Clinical Practice
- (2015) John W. J. Hinrichs et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial
- (2015) J. Rodon et al. ANNALS OF ONCOLOGY
- Clonal distribution of BCR-ABL1 mutations and splice isoforms by single-molecule long-read RNA sequencing
- (2015) Lucia Cavelier et al. BMC CANCER
- A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance
- (2015) M Dietel et al. CANCER GENE THERAPY
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Are physicians prepared for whole genome sequencing? a qualitative analysis
- (2015) K.D. Christensen et al. CLINICAL GENETICS
- Understanding next generation sequencing in oncology: A guide for oncologists
- (2015) Sing Yu Moorcraft et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform
- (2015) Amber Johnson et al. DRUG DISCOVERY TODAY
- Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials
- (2015) David M. Hyman et al. DRUG DISCOVERY TODAY
- Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials
- (2015) Funda Meric-Bernstam et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials
- (2015) Christophe Le Tourneau et al. JNCI-Journal of the National Cancer Institute
- Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
- (2015) Christophe Le Tourneau et al. LANCET ONCOLOGY
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- Frequent expression of PD-L1 on circulating breast cancer cells
- (2015) Martine Mazel et al. Molecular Oncology
- Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
- (2015) Kornelius Schulze et al. NATURE GENETICS
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- ClinVar: public archive of interpretations of clinically relevant variants
- (2015) Melissa J. Landrum et al. NUCLEIC ACIDS RESEARCH
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
- (2015) Leticia De Mattos-Arruda et al. Nature Communications
- Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials
- (2015) Christophe Le Tourneau et al. JNCI-Journal of the National Cancer Institute
- ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma
- (2014) David E. Reuss et al. ACTA NEUROPATHOLOGICA
- Refining the structure and content of clinical genomic reports
- (2014) Michael O. Dorschner et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS
- Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue
- (2014) D. W. Scott et al. BLOOD
- Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens
- (2014) Torsten Nielsen et al. BMC CANCER
- Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow
- (2014) Glenn Deng et al. BMC CANCER
- A systematic approach to the reporting of medically relevant findings from whole genome sequencing
- (2014) Heather M McLaughlin et al. BMC Medical Genetics
- Circulating MicroRNA Biomarker Studies: Pitfalls and Potential Solutions
- (2014) K. W. Witwer CLINICAL CHEMISTRY
- Clinical Utility of a Plasma-Based miRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study
- (2014) Gabriella Sozzi et al. JOURNAL OF CLINICAL ONCOLOGY
- Physicians' Attitudes About Multiplex Tumor Genomic Testing
- (2014) Stacy W. Gray et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
- (2014) François-Clément Bidard et al. LANCET ONCOLOGY
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology
- (2014) Daoud Sie et al. CELLULAR ONCOLOGY
- Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
- (2013) Neal I. Lindeman et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers
- (2013) Akihiko Yoshida et al. MODERN PATHOLOGY
- Tumour heterogeneity in the clinic
- (2013) Philippe L. Bedard et al. NATURE
- Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
- (2013) Irène Baccelli et al. NATURE BIOTECHNOLOGY
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations
- (2012) Erik Thunnissen et al. VIRCHOWS ARCHIV
- Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
- (2011) Jorja D Warren et al. BMC Medicine
- Genome-scale analysis of aberrant DNA methylation in colorectal cancer
- (2011) T. Hinoue et al. GENOME RESEARCH
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The NIH Roadmap Epigenomics Mapping Consortium
- (2010) Bradley E Bernstein et al. NATURE BIOTECHNOLOGY
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
- (2008) J. S. de Bono et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started